# DEX vs SEVO in Congenital Heart Surgery

> **NCT05369949** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 150 (estimated)

## Conditions studied

- Heart Defects, Congenital

## Interventions

- **DRUG:** DEX group
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT05369949
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-01-05
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369949, "DEX vs SEVO in Congenital Heart Surgery". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05369949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*